Henlius and Sandoz Enter Strategic Collaboration to Unlock Global Value of Biosimilars PlatformPR Newswire·2 days ago, 11:08 PMSDZNY+3.13%02696-2.53%
HENLIUS Reaches Global Strategic Partnership With Sandoz, Invoiceable Amt Expected to Reach USD100.5M This YearAASTOCKS News·2 days ago, 08:06 PM02696-2.53%SDZNY+3.13%
Henlius Strikes Global Biosimilar Alliance with SandozTip Ranks·2 days ago, 07:09 PM02696-2.53%SDZNY+3.13%
Sandoz partners with Henlius on up to 10 biosimilars in USD 322 million dealPUBT·2 days ago, 07:00 PMSDZNY+3.13%02696-2.53%
Henlius and Sandoz Enter Strategic Collaboration to Unlock Global Value of Biosimilars Platform | SDZNY Stock NewsStockTitan·Aug 16 at 03:08 PM02696-2.53%SDZNY+3.13%
Liquidia Corp 2026: Revenue $171.68M, EPS $0.74— 10-Q SummaryTradingView·Aug 12 at 05:51 AMLQDA+1.35%LGM
SDZ: Biosimilars drove 5% sales growth and margin expansion, offsetting legal costs in H1 2026Quartr·Aug 5 at 12:10 AMSDZNY+3.13%
Evotec publishes company presentation outlining drug discovery strategy and outlookPUBT·Aug 4 at 11:20 AMEVO+3.66%EVT
Sandoz agrees to pay USD 400 million to settle US generic drug pricing claims by 43 statesPUBT·Aug 3 at 12:00 AMSDZNY+3.13%
Sandoz partners with Adalvo to commercialize semaglutide in Brazil after ANVISA approvalPUBT·Jul 29 at 04:30 AMSDZNY+3.13%
Sandoz to Engage With U.S. Policymakers After Trump's Tariff PlanMorningStar·Jul 22 at 01:28 AMSDZNY+3.13%
Sandoz names Pascal Bouye as generics manufacturing and supply chiefPUBT·Jul 15 at 12:00 AMSDZNY+3.13%
17:00 ETFine, Kaplan and Black, R.P.C. announced that if you paid or reimbursed certain prescription generic drug costs in the United States between May 1, 2009, and December 31, 2019, you can now submit a class action settlement claim formprnewswire·Jul 10 at 04:01 PMSDZNY+3.13%
